Post-infection cellular immune responses in recipients following ALVAC-HIV® plus AIDSVAX® B/E prime-boost vaccination in the Thai Phase III Trial

被引：0
|
作者：
Kim, J. H. [1 ]
Kamasuta, C. [2 ]
Trichavaroj, R. [2 ]
Kaewkungwal, J. [3 ]
Chantakulkij, S. [2 ]
Ratto-Kim, S. [1 ]
Eamsila, C. [2 ]
Sukwit, S. [2 ]
Nitayaphan, S. [2 ]
Pitsuttihum, P. [3 ]
Michael, N. L. [1 ]
Chiu, J. [2 ]
Rerks-Ngarm, S. [4 ]
de Souza, M. S. [2 ]
Paris, R. M. [2 ]
机构：
[1] US Mil HIV Res Program, Rockville, MD USA
[2] US Mil HIV Res Program AFRIMS, Bangkok, Thailand
[3] Mahidol Univ, Vaccine Trial Ctr, Fac Trop Med, Bangkok 10700, Thailand
[4] Minist Publ Hlth, Nonthaburi, Thailand
来源：
RETROVIROLOGY | 2009年 / 6卷
关键词：
Viral Load; Peripheral Blood Mononuclear Cell; ELISpot Assay; Chromium Release Assay; Median Viral Load;
D O I：
10.1186/1742-4690-6-S3-O30
中图分类号：
Q93 [微生物学];
学科分类号：
071005 ; 100705 ;
摘要：
引用
收藏
页数：1
相关论文
共 13 条
  • [1] OA04-06 LB. Post-infection cellular immune responses in recipients following ALVAC-HIV® + AIDSVAX® B/E prime-boost vaccination in the Thai Phase III Trial
    JH Kim
    C Kamasuta
    R Trichavaroj
    J Kaewkungwal
    S Chantakulkij
    S Ratto-Kim
    C Eamsila
    S Sukwit
    S Nitayaphan
    P Pitsuttihum
    NL Michael
    J Chiu
    S Rerks-Ngarm
    MS de Souza
    RM Paris
    Retrovirology, 6
  • [2] Immune Correlates of Infection Risk in the Thai Phase III ALVAC-HIV/AIDSVA-B/E Prime Boost Study
    Michael, Nelson L.
    JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES, 2012, 59 : 46 - 46
  • [3] ALVAC-HIV and AIDSVAX B/E vaccination induce improved immune responses compared with AIDSVAX B/E vaccination alone
    Costanzo, Margaret C.
    Paquin-Proulx, Dominic
    Schuetz, Alexandra
    Akapirat, Siriwat
    Shubin, Zhanna
    Kim, Dohoon
    Wieczorek, Lindsay
    Polonis, Victoria R.
    Trinh, Hung V.
    Rao, Mangala
    Anenia, Hanna
    Barrera, Michael D.
    Boeckelman, Jacob
    Nails, Barbara
    Thapa, Pallavi
    Zemil, Michelle
    Sacdalan, Carlo
    Kroon, Eugene
    Kaewboon, Boot
    Tipsuk, Somporn
    Jongrakthaitae, Surat
    Gurunathan, Sanjay
    Sinangil, Faruk
    Kim, Jerome H.
    Robb, Merlin L.
    Ake, Julie A.
    O'Connell, Robert J.
    Pitisutthithum, Punnee
    Nitayaphan, Sorachai
    Chariyalertsak, Suwat
    Eller, Michael A.
    Phanuphak, Nittaya
    Vasan, Sandhya
    JCI INSIGHT, 2023, 8 (09)
  • [4] Immunogenicity of ALVAC-HIV® (vCP1521) and AIDSVAX® B/E prime boose vaccination in RV144, the Thai Phase III HIV vaccine trial
    de Souza, M. S.
    Trichavaroj, R.
    Schuetz, A.
    Chuenarom, W.
    Phuang-ngem, Y.
    Jongrakthaitae, S.
    Ratto-Kim, S.
    Nitayaphan, S.
    Dally, L.
    Rerks-Ngam, S.
    Tartaglia, J.
    Francis, D.
    Michael, N. L.
    Paris, R. M.
    Kim, J. H.
    RETROVIROLOGY, 2009, 6
  • [5] Late Boost Strategies of ALVAC-HIV/AIDSVAX B/E® Prime-boost Regimen (RV306) Increased Functional B Cell Responses and Frequency of Plasmablasts
    Chuenarom, Weerawan
    Pitisutthithum, Punnee
    Phuangngern, Yuwadee
    Nitayaphan, Sorachai
    Chariyalertsak, Suwat
    Kaewkungwal, Jaranit
    Kaewboon, Boot
    Phogat, Sanjay
    Karasavvas, Nicos
    Sinangil, Faruk
    Excler, Jean-Louis
    Robb, Merlin
    Michael, Nelson
    Kim, Jerome
    Desouza, Mark
    Connell, Robert O.
    Vasan, Sandhya
    Schuetz, Alexandra
    AIDS RESEARCH AND HUMAN RETROVIRUSES, 2016, 32 : 393 - 393
  • [6] Characterization of HIV-1 Envelope Antibody Responses Following ALVAC-HIV and AIDSVAX B/E Prime-boost Vaccinations with Varying Late Boosts (RV306)
    Akapirat, Siriwat
    Madnote, Sirinan
    Pitisuttithum, Punnee
    Nitayaphan, Sorachai
    Chariyalertsak, Suwat
    Puangkaew, Jiraporn
    Rittiroongrad, Surawach
    Chantakulkij, Somsak
    Phogat, Sanjay
    Sinangil, Faruk
    Excler, Jean-Louis
    Robb, Merlin L.
    Michael, Nelson L.
    Kim, Jerome H.
    Vasan, Sandhya
    Connell, Robert J. O.
    Karasavvas, Nicos
    AIDS RESEARCH AND HUMAN RETROVIRUSES, 2016, 32 : 100 - 100
  • [7] HLA class II restriction of HIV-1 clade-specific neutralizing antibody responses in ethnic Thai recipients of the RV144 prime-boost vaccine combination of ALVAC-HIV and AIDSVAX® B/E
    Paris, Robert
    Bejrachandra, Sasitorn
    Thongcharoen, Prasert
    Nitayaphan, Sorachai
    Pitisuttithum, Punnee
    Sambor, Anna
    Gurunathan, Sanjay
    Francis, Donald
    Ratto-Kim, Silvia
    Karnasuta, Chitraporn
    de Souza, Mark S.
    Polonis, Victoria R.
    Brown, Arthur E.
    Kim, Jerome H.
    Stephens, Henry A.
    VACCINE, 2012, 30 (05) : 832 - 836
  • [8] Antibody-dependent cell-mediated cytotoxic responses in participants enrolled in a phase I/II ALVAC-HIV/AIDSVAX® B/E prime-boost HIV-1 vaccine trial in Thailand
    Karnasuta, C
    Paris, RM
    Cox, JH
    Nitayaphan, S
    Pitisuttithum, P
    Thongcharoen, P
    Brown, AE
    Gurunathan, S
    Tartaglia, J
    Heyward, WL
    McNeil, JG
    Birx, DL
    de Souza, MS
    VACCINE, 2005, 23 (19) : 2522 - 2529
  • [9] Safety and Reactogenicity of ALVAC-HIV (vCP1521) and HIV-1 gp120 AIDSVAX B/E Prime-Boost Vaccination Regimen in a Community-Based Efficacy Trial
    Pitisuttithum, P.
    Rerks-Ngarm, S.
    Bussaratid, V.
    Dhitavat, J.
    Maekanantawat, W.
    Pungpak, S.
    Suntharasamai, P.
    Vanijanonta, S.
    Nitayapan, S.
    Kaewkungwal, J.
    Chunsuttiwat, S.
    Premsri, N.
    Benenson, M.
    Morgan, P.
    Berenberg, J.
    Gurunathan, S.
    Francis, D. P.
    Chiu, J.
    Excler, J.
    Robb, M. L.
    Stablein, D.
    Michael, N. L.
    Kim, J.
    AIDS RESEARCH AND HUMAN RETROVIRUSES, 2011, 27 (10) : A74 - A74
  • [10] OA07-04 LB. Immunogenicity of ALVAC-HIV® (vCP1521) and AIDSVAX® B/E prime boose vaccination in RV144, the Thai Phase III HIV vaccine trial
    MS de Souza
    R Trichavaroj
    A Schuetz
    W Chuenarom
    Y Phuang-ngem
    S Jongrakthaitae
    S Ratto-Kim
    S Nitayaphan
    L Dally
    S Rerks-Ngam
    J Tartaglia
    D Francis
    NL Michael
    RM Paris
    JH Kim
    Retrovirology, 6
12